NovAccess Global Inc.

About NovAccess Global Inc.

NovAccess Global is a company focused on revolutionary advances in understanding how the human body can fight cancer and applying this knowledge to treat existing tumors. Their mission involves strengthening the body's defense against cancer through innovative approaches like their patented immunotherapy candidate, TLR-AD1.

Products & Services

TLR-AD1:A patented immunotherapy candidate designed to bolster the body's immune system through cellular training to fight cancer.

StemVax:A product or division mentioned in the content, likely related to stem cell or vaccine technology for cancer treatment.

Precision Medicine Division:A division using AI, Big Data, and predictive technologies to advance medical solutions.

Specialties

Immunotherapy Cancer Treatment Precision Medicine AI and Big Data in Healthcare Brain Cancer Vaccine Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Securities Purchase and Convertible Note T: - FT: Securities Purchase and Convertible Note	A: 10700000 MR: - FA: 10.7 million FAN: 10700000	D: 2024-01-02 FD: 2024-01-02	1 investors

Securities Purchase and Convertible Note Latest

2024-01-02

$10.7M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dwain Irvin

CEO, CFO, Executive Board Member

A

Anders Bjorklund

C

Christopher Wheeler

President, StemVax Therapeutics Inc.

J

John Cassarini

Executive Board Member

J

Jason Anderson

Executive Board Member

R

Renard Currie

Scientific Advisor

View 8 more team members with Pro

Unlock Full Team Directory

Recent News